about
Down's syndrome-like skeletal abnormalities in Ets2 transgenic miceThe dendritic cell receptor Clec9A binds damaged cells via exposed actin filamentsGene structure and transcript analysis of the human and mouse EGF-TM7 molecule, FIREFunctional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGNHarnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Apoptosis and non-inflammatory phagocytosis can be induced by mitochondrial damage without caspases.Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.Dendritic cells in the thymus contribute to T-regulatory cell induction.CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen.IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes InfectionPutative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cellsDEC-205 is a cell surface receptor for CpG oligonucleotides.Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulusCharacterization of thymic nurse-cell lymphocytes, using an improved procedure for nurse-cell isolationThe dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancementTargeting CLEC9A delivers antigen to human CD141(+) DC for CD4(+) and CD8(+)T cell recognitionImproving vaccines by targeting antigens to dendritic cellsDendritic cells and cancer immunotherapy.CD14 is not involved in the uptake of synthetic CpG oligonucleotides.Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications.Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets.Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma.Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections.Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection.Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection.Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates.Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall.Differential production of inflammatory chemokines by murine dendritic cell subsets.DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats.Evolution of B cell responses to Clec9A-targeted antigen.Anti-CD2 producing pig xenografts effect localized depletion of human T cells in a huSCID model.Enhancing immune responses by targeting antigen to DC.Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.Distinct functional capacities of mouse thymic and splenic dendritic cell populations.Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3−/− mice
P50
Q24321587-4402EDDC-BE8B-4634-9818-DA0D75221493Q27678371-A006D9F5-5E8E-414D-8D67-337889E05389Q28244323-8F9BE781-A844-4FC8-BD85-58D6A7D1C8C7Q28590922-7C383711-5B2E-46C3-8820-0567D45898DBQ33659782-9F112810-66C1-4FAA-9EA1-0C825839E919Q34422595-DF8C08A8-7B8F-423B-9CDB-80278E20E482Q34573130-649C796C-D897-4999-A723-38D535F8F73BQ34601754-C84EF1AA-3BC7-4AC9-9C03-33A9742B42F9Q35208349-FFC33E90-0295-42F1-B659-170450B36600Q35988496-3EC46D48-5699-41AA-862C-C27D63EA92ABQ36229056-8B2F6541-B593-4EE1-B870-8EFA9BEF535AQ36343007-F559C9E4-9A8D-471E-AF44-D16A62878204Q36371026-F574F325-D6BA-4BC1-8A95-08DEAE2D66FEQ36511043-6638B24B-3DCD-4D6E-8DD7-37D63A71AC42Q36941087-65C1B785-344D-4232-9A64-66CF70C07AB5Q37277188-CCEC243E-8743-43CE-AA24-CFE04F65B566Q37415235-17EB5A77-E12D-4A65-9E79-BD57B2C6BCB3Q38186943-58E582A6-DBE6-48C4-A1ED-51571B404964Q38289773-FCFF7F13-957D-4643-A161-E7CB883A5F5EQ38649946-0B07D61F-340D-45B7-ACA0-BC69F9476267Q38821711-65BA6D10-7EDE-4D05-80E2-DC41FCAECC4DQ39631497-CC40BA6C-7D80-49DB-B8FE-A5455D0E1E58Q40116701-AD82D206-41D7-434A-AD0D-01CE2A2FCE34Q40408582-0D3CF52A-C5EA-4400-802D-55F6C663F5D4Q40499837-78535257-86E0-4658-8854-FAC03F898DC9Q41546303-CF909905-5038-4BF7-B0CD-EEEB75BCBA46Q41610389-2F8DA0BD-0E33-49FA-8BB9-EF8BB78AB0DEQ41648902-4B5592B6-A89D-43D1-90F3-31302817909BQ42469057-93DFF9D1-73B9-4A40-A2C9-F3DFA8D93EC4Q43755601-B9EAA0A3-B5D3-4A9B-8952-DF39790A8ABAQ45157993-D64DC19F-85D1-4CD1-A645-ABE9EC317351Q46055473-FD02A22A-FD5B-4FD8-81B1-B95C12A9E6FEQ46104542-AEA2F1D0-BB2A-40E6-ADEC-AA023D72A735Q47125471-EE747ECD-476C-4E5D-8E94-04760AAA824AQ52004726-F76514E9-0F34-4D50-83E9-504D6699FA87Q53085484-97C6EF55-B81D-4FF6-B6AB-519FF67B51B9Q53134762-44F6BC78-95AD-4FF2-BE13-3609C3C8D4CBQ53455335-541AF486-6DA2-457E-A3EC-1E6994F3FBC8Q54265746-9E871313-6846-46FF-B178-66FC327D91E5Q57133229-C44D1D62-91E2-4ED5-A21C-1425894B5A22
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mireille H. Lahoud
@ast
Mireille H. Lahoud
@en
Mireille H. Lahoud
@es
Mireille H. Lahoud
@sl
type
label
Mireille H. Lahoud
@ast
Mireille H. Lahoud
@en
Mireille H. Lahoud
@es
Mireille H. Lahoud
@sl
prefLabel
Mireille H. Lahoud
@ast
Mireille H. Lahoud
@en
Mireille H. Lahoud
@es
Mireille H. Lahoud
@sl
P1053
F-1299-2013
P106
P1153
6603830518
P21
P31
P3829
P496
0000-0001-8472-6201